123 related articles for article (PubMed ID: 17679484)
1. Nitrosoureas: molecular pharmacology/ translational research.
D'Incalci M
Tumori; 2007; 93(3):suppl 17-21. PubMed ID: 17679484
[No Abstract] [Full Text] [Related]
2. [Role of MGMT and clinical applications in brain tumours].
Paus C; Murat A; Stupp R; Regli L; Hegi M
Bull Cancer; 2007 Sep; 94(9):769-73. PubMed ID: 17878096
[TBL] [Abstract][Full Text] [Related]
3. [Alkylating agents].
Pourquier P
Bull Cancer; 2011 Nov; 98(11):1237-51. PubMed ID: 22020797
[TBL] [Abstract][Full Text] [Related]
4. [The biochemical mechanisms of the action of N-alkyl-N-nitrosoureas. The possible reasons for drug resistance to these compounds].
Syrkin AB; Gorbacheva LB
Eksp Klin Farmakol; 1996; 59(2):69-75. PubMed ID: 8974572
[TBL] [Abstract][Full Text] [Related]
5. Lipoic acid inhibits the DNA repair protein O 6-methylguanine-DNA methyltransferase (MGMT) and triggers its depletion in colorectal cancer cells with concomitant autophagy induction.
Göder A; Nagel G; Kraus A; Dörsam B; Seiwert N; Kaina B; Fahrer J
Carcinogenesis; 2015 Aug; 36(8):817-31. PubMed ID: 25998848
[TBL] [Abstract][Full Text] [Related]
6. Disulfiram sensitizes pituitary adenoma cells to temozolomide by regulating O6-methylguanine-DNA methyltransferase expression.
Zhao Y; Xiao Z; Chen W; Yang J; Li T; Fan B
Mol Med Rep; 2015 Aug; 12(2):2313-22. PubMed ID: 25937029
[TBL] [Abstract][Full Text] [Related]
7. A novel approach to overcome temozolomide resistance in glioma and melanoma: Inactivation of MGMT by gene therapy.
Jiang G; Wei ZP; Pei DS; Xin Y; Liu YQ; Zheng JN
Biochem Biophys Res Commun; 2011 Mar; 406(3):311-4. PubMed ID: 21329652
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma.
Kohsaka S; Takahashi K; Wang L; Tanino M; Kimura T; Nishihara H; Tanaka S
Cancer Lett; 2013 Apr; 331(1):68-75. PubMed ID: 23246370
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of temozolomide resistance in glioblastoma multiforme.
Johannessen TC; Bjerkvig R
Expert Rev Anticancer Ther; 2012 May; 12(5):635-42. PubMed ID: 22594898
[TBL] [Abstract][Full Text] [Related]
10. Transfection of a human glioblastoma cell line with liver-type glutaminase (LGA) down-regulates the expression of DNA-repair gene MGMT and sensitizes the cells to alkylating agents.
Szeliga M; Zgrzywa A; Obara-Michlewska M; Albrecht J
J Neurochem; 2012 Nov; 123(3):428-36. PubMed ID: 22888977
[TBL] [Abstract][Full Text] [Related]
11. Multidrug Efflux Pumps Attenuate the Effect of MGMT Inhibitors.
Tomaszowski KH; Schirrmacher R; Kaina B
Mol Pharm; 2015 Nov; 12(11):3924-34. PubMed ID: 26379107
[TBL] [Abstract][Full Text] [Related]
12. [Regulation of MGMT and application for the therapy to attenuate the chemoresistance].
Kohsaka S; Kanno H; Tanaka S
Nihon Rinsho; 2012 Nov; 70 Suppl 8():346-52. PubMed ID: 23513864
[No Abstract] [Full Text] [Related]
13. Repairing of N-mustard derivative BO-1055 induced DNA damage requires NER, HR, and MGMT-dependent DNA repair mechanisms.
Kuo CY; Chou WC; Wu CC; Wong TS; Kakadiya R; Lee TC; Su TL; Wang HC
Oncotarget; 2015 Sep; 6(28):25770-83. PubMed ID: 26208482
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study.
Boccard SG; Marand SV; Geraci S; Pycroft L; Berger FR; Pelletier LA
Oncotarget; 2015 Oct; 6(30):29456-68. PubMed ID: 26336131
[TBL] [Abstract][Full Text] [Related]
15. MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma.
Donson AM; Addo-Yobo SO; Handler MH; Gore L; Foreman NK
Pediatr Blood Cancer; 2007 Apr; 48(4):403-7. PubMed ID: 16609952
[TBL] [Abstract][Full Text] [Related]
16. Chloroethylating nitrosoureas in cancer therapy: DNA damage, repair and cell death signaling.
Nikolova T; Roos WP; Krämer OH; Strik HM; Kaina B
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):29-39. PubMed ID: 28143714
[TBL] [Abstract][Full Text] [Related]
17. Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression.
Perazzoli G; Prados J; Ortiz R; Caba O; Cabeza L; Berdasco M; Gónzalez B; Melguizo C
PLoS One; 2015; 10(10):e0140131. PubMed ID: 26447477
[TBL] [Abstract][Full Text] [Related]
18. O6-alkylguanine-DNA alkyltransferase. A target for the modulation of drug resistance.
Gerson SL; Willson JK
Hematol Oncol Clin North Am; 1995 Apr; 9(2):431-50. PubMed ID: 7642472
[TBL] [Abstract][Full Text] [Related]
19. MGMT immunoexpression predicts responsiveness of pituitary tumors to temozolomide therapy.
Kovacs K; Scheithauer BW; Lombardero M; McLendon RE; Syro LV; Uribe H; Ortiz LD; Penagos LC
Acta Neuropathol; 2008 Feb; 115(2):261-2. PubMed ID: 17926052
[No Abstract] [Full Text] [Related]
20. Medical treatment and other combination regimens.
Bajetta E; Del Vecchio M; Bajetta R; Canova S
Tumori; 2007; 93(3):suppl 22-6. PubMed ID: 17679485
[No Abstract] [Full Text] [Related]
[Next] [New Search]
